{"id":3102,"date":"2018-08-24T09:50:59","date_gmt":"2018-08-24T04:20:59","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=3102"},"modified":"2021-07-24T12:57:02","modified_gmt":"2021-07-24T07:27:02","slug":"japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","title":{"rendered":"Japan Manages to Stand Apart from Global Hepato Cellular Carcinoma Crowd"},"content":{"rendered":"

Hepato Cellular Carcinoma (HCC)<\/a><\/p>\n

Not all deadly battles are lost. Some are won too.It is without the slightest doubt that the ones won are the typical examples of smart management, involving implementation of prudent steps, guided by the knowledge of every nook and corner. Undoubtedly, these examples not only serve as useful lessons for the mankind to follow but also instill confidence among the fighters to continue fighting on. Such won battles also exemplify the age-old adage\u2014\u2018nothing is impossible\u2019.<\/p>\n

One of the deadly battles in the world is the fight against Hepato Cellular Carcinoma (HCC) [or Liver Cancer for the commoners], which has proliferated across all geographies, affecting huge number of persons every passing year and eliminating many lives from the earth. Despite growing awareness of the disease and the improvements in treatment methodologies, there has been no retardation to the growing spread of the deadly disease all over the world, posing as a major threat to the world population.<\/p>\n

A research on the global pattern of the disease was done by DelveInsight, a premier healthcare research & consulting firm based at New Delhi in India; that showed the dreaded disease is actively on a propagating spree, sparing not even population in the developed nations of the world, leave alone the population of under-developed and developing geographies.<\/p>\n

It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels. The incident patterns in the respective G8 countries are expected to exhibit rising trends in the coming years barring Japan, in which the trend is likely to be the opposite.<\/p>\n

Amidst the havoc unleased by the disease worldwide, Japan has interestingly managed to stand apart from the global HCC crowd, thanks to the implementation of effective initiatives in that South East Asian country. DelveInsight\u2019s research shows the prospect of the Japanese population coming under the grip of the disease is gradually losing strength, and the loosening trend is expected to continue in the coming years, thus bringing onto the horizon the optimistic prospect of the incidence of the disease getting lower in the future.<\/p>\n

But what made Japan to stand apart from the global HCC crowd despite the availability of similar treatment methodologies and medications as in the rest of the world geographies? The answer is: smart management.<\/p>\n

In the South East Asian country, there have been constant efforts directed towards striking at the root causes of the disease along with implementation of measures for early detection and awareness generation.<\/p>\n

In Japan, the establishment of a Nationwide Liver Cancer Screening Program in 1980s was the first step towards the awareness generation. The program, mentored by several leading institutes of the country, is believed to be the foremost factor for creating a mass awareness among the population of that nation.<\/p>\n

Physicians in Japan have actuated striking at the root causes of the disease that involved predominantly treating the Hepatitis-C Virus (HCV) infection, which is one of the major underlying causes for the occurrence of HCC. Their efforts also involved implementing preventive measures, such as mass vaccination of the newborns against the Hepatitis infection, screening of blood donors and emphasizing upon early diagnosis of HCC. And at the same, Japanese physicians have implemented the most advanced and effective treatment methodologies.<\/p>\n

As the bottom-line, the threat of HCC looming on the Japanese population is going to ease significantly.<\/p>\n

**Wish to understand the global HCC market in-depth, especially in terms of: the disease pattern in various geographies, the treatments & drugs in vogue, upcoming drugs and, the current and future global market size? Then, wait no further. Get in touch with Shruti Thakur [( +91) 8377017624, <\/em>sthakur@delveinsight.com<\/em><\/a> ] to purchase the comprehensive report by DelveInsight–<\/em> Hepatocellular Carcinoma: Market Insights, Epidemiology and Market Forecast-2027<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Hepato Cellular Carcinoma (HCC) Not all deadly battles are lost. Some are won too.It is without the slightest doubt that the ones won are the typical examples of smart management, involving implementation of prudent steps, guided by the knowledge of every nook and corner. Undoubtedly, these examples not only serve as useful lessons for the […]<\/p>\n","protected":false},"author":1,"featured_media":3103,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[5999,17665,290,5996,4243],"industry":[17225],"therapeutic_areas":[17228],"class_list":["post-3102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-hcc","tag-hcc-market","tag-hepatitis-c-virus","tag-hepatocellular-carcinoma","tag-liver-cancer","industry-pharmaceutical","therapeutic_areas-oncology"],"acf":[],"yoast_head":"\nJapan Manages to Stand Apart from Global HCC Crowd | Delveinsight<\/title>\n<meta name=\"description\" content=\"It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Japan Manages to Stand Apart from Global HCC Crowd | Delveinsight\" \/>\n<meta property=\"og:description\" content=\"It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-24T04:20:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:27:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Japan Manages to Stand Apart from Global HCC Crowd | Delveinsight","description":"It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","og_locale":"en_US","og_type":"article","og_title":"Japan Manages to Stand Apart from Global HCC Crowd | Delveinsight","og_description":"It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels.","og_url":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2018-08-24T04:20:59+00:00","article_modified_time":"2021-07-24T07:27:02+00:00","og_image":[{"width":500,"height":375,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","url":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd","name":"Japan Manages to Stand Apart from Global HCC Crowd | Delveinsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer.jpg","datePublished":"2018-08-24T04:20:59+00:00","dateModified":"2021-07-24T07:27:02+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"It was found in the research that by 2027, the total incident HCC cases in the G8 countries will go up significantly from the current levels.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/japan-manages-to-stand-apart-from-global-hepato-cellular-carcinoma-crowd#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer.jpg","width":500,"height":375,"caption":"HCC"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/08\/09021353\/liver_cancer-300x225.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">HCC<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">HCC Market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Hepatitis C Virus<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Hepatocellular Carcinoma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Liver cancer<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">HCC<\/span>","<span class=\"advgb-post-tax-term\">HCC Market<\/span>","<span class=\"advgb-post-tax-term\">Hepatitis C Virus<\/span>","<span class=\"advgb-post-tax-term\">Hepatocellular Carcinoma<\/span>","<span class=\"advgb-post-tax-term\">Liver cancer<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 8 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Aug 24, 2018","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Aug 24, 2018 9:50 am","modified":"Updated on Jul 24, 2021 12:57 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=3102"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/3103"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=3102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=3102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=3102"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=3102"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=3102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}